Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SANUWAVE Health (SNWV) EPS (Weighted Average and Diluted) (2019 - 2026)

SANUWAVE Health has reported EPS (Weighted Average and Diluted) over the past 12 years, most recently at -$0.17 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 76.39% to -$0.17 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.96 through Mar 2026, up 111.31% year-over-year, with the annual reading at $0.41 for FY2025, 105.53% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.17 for Q1 2026 at SANUWAVE Health, down from $0.78 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $11.96 in Q4 2023 and troughed at -$9.95 in Q3 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.02 (2023), against an average of -$0.44.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 119700.0% in 2023 against a maximum downside of 473800.22% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.01 in 2022, then surged by 119700.0% to $11.96 in 2023, then crashed by 109.36% to -$1.12 in 2024, then skyrocketed by 169.64% to $0.78 in 2025, then plummeted by 121.79% to -$0.17 in 2026.
  • Per Business Quant, the three most recent readings for SNWV's EPS (Weighted Average and Diluted) are -$0.17 (Q1 2026), $0.78 (Q4 2025), and $0.39 (Q3 2025).